Back to Immunity
SupplementPreliminary evidenceImmunity

Mulberry leaf (Morus alba, DNJ)

Asian leaf containing 1-deoxynojirimycin (DNJ), preliminary RCT signal for postprandial glucose blunting via α-glucosidase inhibition.

Why

White mulberry (Morus alba) leaf has long-standing use in TCM and Japanese folk medicine for diabetes. The active 1-deoxynojirimycin (DNJ), also the basis for the pharmaceutical miglitol, is an α-glucosidase inhibitor that blunts postprandial glucose. Small RCTs (Mudra 2007 Diabetes Care, Asai 2011) confirm postprandial glucose reduction in mild T2DM and healthy adults.

How it works

DNJ competitively inhibits intestinal α-glucosidase, delaying carbohydrate hydrolysis and reducing postprandial glucose spike, same mechanism as pharmaceutical miglitol and acarbose. Independent effects on hepatic glucose output and oxidative stress documented in animal models.

Expected onset · Postprandial glucose effect acute (with the meal)

How to take

Dosage

Standardised mulberry leaf extract: 1,000 mg before each main meal, or stated DNJ content (5–20 mg per dose).

Timing

10–15 minutes before main meals

On the label

Standardised mulberry leaf with stated DNJ (1-deoxynojirimycin) content, most clinical work uses ~12–25 mg DNJ per dose.

Ideal for

Adults with prediabetes, postprandial hyperglycaemia, or metabolic syndrome exploring botanical glucose-blunting.

Safety

Same GI side effects as pharmaceutical α-glucosidase inhibitors at higher doses, gas, bloating, loose stool (undigested carbohydrate reaching the colon). Hypoglycaemia risk additive with insulin and sulphonylureas. Pregnancy and breastfeeding data limited.

Evidence

At a glance

Mudra 2007 Diabetes Care RCT (n=48 T2DM and controls): mulberry leaf extract significantly reduced postprandial glucose AUC after sucrose challenge in both groups. Asai 2011 confirmed signal at lower DNJ doses. Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.

Limitations

Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.

Where to get it

Shop Mulberry leaf (Morus alba, DNJ) on Amazon

Sponsored · As an Amazon Associate, Healicus earns from qualifying purchases.